<DOC>
	<DOCNO>NCT01790685</DOCNO>
	<brief_summary>To measure pro-permeability factor aqueous humor patient persistent/recurrent macular edema injection Ozurdex .</brief_summary>
	<brief_title>Ozurdex Retinal Vein Occlusion Study ( ORVO Study )</brief_title>
	<detailed_description>To measure various pro-permeability factor aqueous humor patient persistent/recurrent macular edema despite prior treatment anti-VEGF agent baseline 4 week intraocular injection OZURDEX .</detailed_description>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Signed informed consent authorization use disclosure protect health information Age equal 18 year Diagnosis macular edema due central branch retinal vein occlusion Intraretinal subretinal fluid macula determine Spectralis OCT Best correct visual acuity score study eye 20/30 20/400 inclusive ( Snellen equivalent use ETDRS protocol distance 4 meter ) In opinion investigator , decrease vision study eye due foveal thicken vein occlusion obvious cause decrease vision Persistent recurrent edema despite prolonged treatment antiVEFG agent Scatter laser photocoagulation macular photocoagulation within 3 month study entry study eye Intraocular surgery study eye within 3 month study entry Use intraocular periocular injection steroid study eye ( e.g. , triamcinolone ) within 4 month study entry Previous use antiVEGF drug within 1 month study entry YttriumAluminumGarnet ( YAG ) laser capsulotomy within 1 month study entry Any condition investigator believe would pose significant hazard subject investigational therapy initiate . Inability comply study follow procedure History glaucoma document history steroidinduced glaucoma . Patients active suspect ocular periocular infection , include viral disease cornea conjunctiva , include active epithelial herpes simplex keratitis ( dendritic keratitis ) , vaccinia , varicella , mycobacterial infection , fungal disease . Aphakic eyes rupture posterior lens capsule . Eyes ACIOL rupture posterior lens capsule . Patients hypersensitivity dexamethasone component product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>